Back to results
US 2010/0076017 A1Published application
Sitamaquine tosylate for the treatment of leishmaniasis
OwnerAndrew David Searleinventor
Life of this patent
Estimating the term…
Abstract
Disclosed in a novel compound of formula (IA) and its use in the treatment of leishmaniasis infections.
Claims4
1-4. (canceled)
A compound which is sitamaquine tosylate of structure (1 A):
Dependencies are inferred from the claim text.